Checchi Capital Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $799K | Sell |
1,794
-41
| -2% | -$18.3K | 0.04% | 246 |
|
|
2025
Q1 | $890K | Buy |
1,835
+31
| +2% | +$15K | 0.05% | 225 |
|
|
2024
Q4 | $726K | Sell |
1,804
-13
| -0.7% | -$5.24K | 0.04% | 245 |
|
|
2024
Q3 | $845K | Buy |
1,817
+12
| +0.7% | +$5.58K | 0.05% | 218 |
|
|
2024
Q2 | $846K | Buy |
1,805
+118
| +7% | +$55.3K | 0.04% | 213 |
|
|
2024
Q1 | $705K | Buy |
1,687
+24
| +1% | +$10K | 0.06% | 254 |
|
|
2023
Q4 | $677K | Buy |
1,663
+22
| +1% | +$8.95K | 0.05% | 241 |
|
|
2023
Q3 | $571K | Sell |
1,641
-553
| -25% | -$192K | 0.05% | 255 |
|
|
2023
Q2 | $772K | Buy |
2,194
+485
| +28% | +$171K | 0.07% | 206 |
|
|
2023
Q1 | $538K | Buy |
1,709
+10
| +0.6% | +$3.15K | 0.05% | 272 |
|
|
2022
Q4 | $491K | Buy |
1,699
+116
| +7% | +$33.5K | 0.05% | 279 |
|
|
2022
Q3 | $458K | Buy |
1,583
+23
| +1% | +$6.65K | 0.04% | 280 |
|
|
2022
Q2 | $437K | Buy |
1,560
+130
| +9% | +$36.4K | 0.04% | 317 |
|
|
2022
Q1 | $373K | Buy |
1,430
+297
| +26% | +$77.5K | 0.03% | 340 |
|
|
2021
Q4 | $249K | Sell |
1,133
-103
| -8% | -$22.6K | 0.02% | 437 |
|
|
2021
Q3 | $224K | Sell |
1,236
-82
| -6% | -$14.9K | 0.02% | 448 |
|
|
2021
Q2 | $266K | Sell |
1,318
-81
| -6% | -$16.3K | 0.03% | 417 |
|
|
2021
Q1 | $301K | Sell |
1,399
-88
| -6% | -$18.9K | 0.03% | 347 |
|
|
2020
Q4 | $351K | Sell |
1,487
-222
| -13% | -$52.4K | 0.04% | 294 |
|
|
2020
Q3 | $465K | Buy |
1,709
+103
| +6% | +$28K | 0.05% | 208 |
|
|
2020
Q2 | $466K | Buy |
1,606
+208
| +15% | +$60.4K | 0.06% | 206 |
|
|
2020
Q1 | $333K | Sell |
1,398
-69
| -5% | -$16.4K | 0.03% | 227 |
|
|
2019
Q4 | $321K | Buy |
1,467
+8
| +0.5% | +$1.75K | 0.04% | 278 |
|
|
2019
Q3 | $247K | Buy |
1,459
+48
| +3% | +$8.13K | 0.03% | 334 |
|
|
2019
Q2 | $259K | Buy |
1,411
+231
| +20% | +$42.4K | 0.03% | 326 |
|
|
2019
Q1 | $217K | Sell |
1,180
-59
| -5% | -$10.9K | 0.03% | 356 |
|
|
2018
Q4 | $205K | Sell |
1,239
-360
| -23% | -$59.6K | 0.03% | 328 |
|
|
2018
Q3 | $308K | Buy |
1,599
+39
| +3% | +$7.51K | 0.04% | 303 |
|
|
2018
Q2 | $265K | Buy |
1,560
+144
| +10% | +$24.5K | 0.03% | 319 |
|
|
2018
Q1 | $231K | Buy |
1,416
+78
| +6% | +$12.7K | 0.03% | 347 |
|
|
2017
Q4 | $201K | Buy |
+1,338
| New | +$201K | 0.03% | 386 |
|
|
2016
Q3 | – | Sell |
-1,763
| Closed | -$152K | – | 1185 |
|
|
2016
Q2 | $152K | Buy |
1,763
+73
| +4% | +$6.29K | 0.02% | 416 |
|
|
2016
Q1 | $134K | Sell |
1,690
-291
| -15% | -$23.1K | 0.03% | 463 |
|
|
2015
Q4 | $249K | Buy |
+1,981
| New | +$249K | 0.06% | 272 |
|
|
2015
Q3 | – | Sell |
-1,629
| Closed | -$201K | – | 372 |
|
|
2015
Q2 | $201K | Buy |
+1,629
| New | +$201K | 0.05% | 334 |
|